Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 8: AMD II

11:00 - 12:30 | 21 September | Room: Room D5.

Back to Previous

11:00The clinical and imaging spectrum of peripheral exudative hemorrhagic chorioretinopathy
I. Mantel Switzerland
11:06Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96-week results of the ALTAIR study
M. Ohji Japan
11:12Efficacy of intravitreal aflibercept administered using treatandextend regimen over 2 years in patients with neovascular agerelated macular degeneration: baseline characteristics of ARIES
P. Mitchell Australia
11:18Differential diagnostics of reticular pseudodruses based on modern research methods
M. Dalalishvili Russian Federation
11:24Validation of the RetmarkerAMD software for the grading of AMD
J. Marques Portugal
11:30Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for agerelated macular degeneration
D. Barthelmes Switzerland
11:36Tolerating subretinal fluid in the treatment of neovascular agerelated macular degeneration with ranibizumab using a treat and extend regimen: 24 month results from the randomised, multicentre, single masked FLUID study
R. Guymer Australia
11:42Type 3 neovascularization (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real world outcomes at 24 months
A. Invernizzi Italy
11:48Progression of Stargardt disease as measured by spectraldomain optical coherence tomography (SDOCT) in the ProgStar Study
R. Strauss Austria
11:54Longterm visual outcomes for a treat and extend antivascular endothelial growth factor regimen in eyes with neovascular agerelated macular degeneration: Up to nineyear follow up
A. Dirani Canada
12:06OCT Angiography: Real world experience in neovascular AMD new patient clinic using the topcon DRI OCT triton
R. Perrott-Reynolds United Kingdom
12:12Chronic central serous retinopathy (CSR) and type 1 occult neovascularization
M. Nelson United States
12:18Bevacizumab injection in patients with neovascular agerelated macular degeneration increases angiogenic biomarkers
L. Lima Brazil
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait